Hemostemix has terminated the settlement agreement (OTCQB: HMTXF
The hemostemix and aspire health science interdependence settlement agreement has now been completed, permitting managers to concentrate on strategic business development efforts
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。